Skip to main content
OpenTrials
Completed

NCT Number: NCT03321175

Evaluation the Impact of Subcutaneous Irrigation on Wound Complications

to evaluate the effect of subcutaneous irrigation on wound complications

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Kanuni SSTRH

Istanbul, Turkey (Türkiye)

About this study

Cesarean section is the most common abdominal operation performed worldwide. As with every other surgical procedure, it is sometimes accompanied by surgical complications. Wound complications are encountered in approximately 5% of women that undergo CS and include haematomas, seromas and infection. To evaluate the effects and benefits of subcutaneous irrigation during cesarean section we decide to conduct this randomized study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-40, undergoing cesarean section

Exclusion criteria

  • patients with systemical disease, body mass index>30

Treatment and study plan

subcutaneous saline irrigation

Other

200 cc saline irrigation

Primary outcomes

  1. wound complications

    Time frame: 1 week

    wound complications will be evaluated 1 week after the surgery.

Sponsors and collaborators

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Other

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Oct 25, 2017
Registry last updated
Apr 4, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.